Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

How mifepristone became a target of the US anti-abortion movement

The abortion pill, first invented in 1980 in France, was slow to be accepted in the US. Now, it’s at the center of a major court fight

The Guardian - US

Australian pharmacy losses predicted to total $1.2bn over four years under Labor prescription reforms

Government models also outline benefits to patients as guild says changes will send small and regional businesses ‘to the wall’

The Guardian - AU

US sues to block $28 bn Amgen biopharma acquisition

New York (AFP) - US regulators filed a lawsuit Tuesday to block biopharmaceutical firm Amgen's proposed $28 billion takeover of drug maker Horizon Therapeutics, saying the transaction would harm consumers.

AFP

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Buy Worthy Biotech Stocks for May

The biotech industry is well-positioned to witness significant growth with government support and breakthrough developments. Therefore, biotech stocks BioNTech SE (BNTX), Acorda Therapeutics (ACOR), and Shionogi (SGIOY) might be solid buys. Read on.

StockNews.com

Eli Lilly's Alzheimer's Drug Is Just Version 1.0. But It's Still On Track For Blockbuster Status, Analyst Says.

Lilly's Alzheimer's treatment could reach blockbuster status by 2025, an analyst said Monday. Eli Lilly stock is trading near a record high.

Investors Business Daily

3 Biotech Stocks Poised to Skyrocket

On the backs of successful trials and breakthrough therapies, the biotech market is poised to thrive. Therefore, scooping up the shares of fundamentally sound biotech stocks such as BioMarin Pharmaceutical (BMRN), Incyte Corp. (INCY), and Innoviva (INVA) could be beneficial. Read more….

StockNews.com

University of Bristol spin-out secures £415,000 for disease detection tech

Rosa Biotech said it would use the money to accelerate testing of its platform, which acts as a biosensor on patient blood samples

Birmingham Post

Read news from The Economist, FT, and more,
with one subscription

Healthcare firm owned by Tory grandee landed £53million in NHS contracts

Tory grandee Lord Ashcroft controlled Medacs Healthcare when it was handed 10 NHS deals worth up to £53million between September 2021 and December 2022, contract notices have revealed

Daily Mirror

Best Medical Stock Investors Should Buy in a Recession

Despite the cooling down of inflation, a Fed rate cut is not in sight. Amid recessionary concerns, investing in medical stock Abbott Laboratories (ABT) could be wise given its sound financials and the inherent stability of the medical sector. Let’s take a look at some of the company’s key metrics….

StockNews.com

2 Pharma Stocks Poised for Record-Breaking Growth

Due to innovative drug development and increasing demand for healthcare, the pharma industry is poised to thrive in the foreseeable future. Given the significant prospects of the industry, pharma stocks Novo Nordisk A/S (NVO) and Novartis AG (NVS) look poised for solid growth and might be ideal additions to one’s…

StockNews.com

Top 3 Biotech Stocks with Breakout Potential

The biotech industry is well-positioned to witness significant growth due to technological advancements and government spending. Moreover, given the sector’s defensive nature, biotech stocks Amicus Therapeutics (FOLD), Corcept Therapeutics (CORT), and Harmony Biosciences (HRMY) might be solid buys in 2023. Read on.

StockNews.com

DCGI calls for bridging bio-tech interface to get out of generic mindset

The Hindu

Catalyst CEO Says 'We Hit The Ball Out Of The Park,' But Shares Of IBD 50 Stock Crash

No. 1 biotech stock Catalyst Pharmaceuticals put up a mixed first quarter Thursday, which took a heavy toll on the company's shares.

Investors Business Daily

One of UK's biggest 'Breaking Bad' labs flooded streets with drugs worth £10m a MONTH

John Keet invested profits from a career dealing cocaine, cannabis and amphetamines into building and managing the lab in Henley-in-Arden, a quaint market town in Warwickshire

Daily Mirror

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Staff shortages force pharmacies to close for 100,000 hours in a year amid plans to give them more work

Exclusive: It comes as experts warn plans to move work from GPs to pharmacies will have ‘marginal’ impact on GP crisis

Investors Business Daily

This Botox Rival Has Investors Frowning After Missing Q1 Earnings Estimates. The Stock Reversed Course After The Report.

Revance Therapeutics, a biotech stock, reported earnings late Tuesday. Shares are tanking after the numbers surprised investors.

StockNews.com

3 Growth Stocks to Buy Now

As a slowdown in monetary policy tightening is paving its way, the possibility of a soft landing still stands. Therefore, it could be an ideal opportunity for investors to load up on some fundamentally sound growth stocks, Novartis (NVS), Daimler Truck Holding (DTRUY), and CPI Aerostructures (CVU). Read on….

StockNews.com

2 Most Promising Biotech Stocks to Buy

Given the breakthrough developments and government initiatives, the biotech industry is well-positioned to grow steadily. Therefore, fundamentally strong biotech stocks Amicus Therapeutics (FOLD) and POINT Biopharma (PNT) could be worth buying now. Read on.

Get all your
news in one place.

100’s of premium titles.
One news app.

Chronicle Live

“I’m 78 and my youthful skin is all down to this £10 Boots anti-ageing serum”

The No7 anti-ageing serum is usually £34.95 and has been reduced to £10 as part of Boots' weekly £10 Tuesday offers

The Guardian - UK

Pharmacies in England to offer prescriptions for seven conditions amid surgery crisis

Proposal is designed to free up 15m GP appointments over the next two years

StockNews.com

No. 1 Undervalued Stock in May

Leading healthcare company McKesson’s (MCK) stock looks undervalued at its current price and could be an excellent pick for value investors. Let’s look at some of MCK’s key metrics.

Newsroom.co.nz

Roadside drug testing could have gone ahead on time - Police Association

The Police Association says alternative policy could have been pushed through in order to enable roadside drug testing on time.

The Independent UK

Warning of more pharmacy closures ‘unless Government provides urgent funding’

Government proposals to improve access to primary care are expected on Tuesday.

StockNews.com

The Bottom of the Barrel: The Worst Drug Store Stock for Investors

MedAvail Holdings’ (MDVL) net loss widened by nearly 9% in fiscal 2022. The company has been taking some measures to achieve profitability, but it still looks far away. Amid this backdrop, investors could consider avoiding the stock. Read more….

Investors Business Daily

Protagonist, A Top 1% Biotech, Briefly Breaks Out On Psoriasis Enthusiasm

Shares of PTGX stock briefly broke out Friday after Protagonist said it plans to soon present new test results for its psoriasis drug.

1 … 38 39 40 41

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the European Commission

University of Bristol

198 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.